一种混合机器学习方法,用于对侵袭性皮肤癌的个性化预后
Tom W Andrew1,2, Mogdad Alrawi3, Ruth Plummer4,5
1Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK. tom.andrew@nhs.net.
NPJ digital medicine
|January 8, 2025
概括
研究人员开发了DeepMerkel,这是一个新的AI工具,用于预测默克尔细胞癌 (MCC) 的存活率. 这种个性化的方法提供了准确的,时间依赖的预测,改进了这种侵袭性皮肤癌的现有分期系统.
科学领域:
- 在瘤学瘤学.
- 人工智能的人工智能
- 生物信息学是一种生物信息学.
背景情况:
- 默克尔细胞癌 (MCC) 是一种具有较低生存率的侵袭性皮肤癌.
- 目前的预后工具缺乏针对MCC患者的个性化.
- 在MCC管理中,需要先进的预后模型.
研究的目的:
- 开发针对默克尔细胞癌 (MCC) 的个性化预后工具.
- 通过可解释性分析识别新的死亡风险因素.
- 创建一个基于Web的工具,用于MCC中准确的,时间依赖的生存预测.
主要方法:
- 采用可解释性分析来发现MCC死亡风险因素.
- 结合深度学习功能选择与修改的XGBoost框架.
- 开发并验证了基于Web的预测工具"DeepMerkel".
主要成果:
- DeepMerkel为MCC提供准确,个性化,时间依赖的生存预测.
- 该工具在国际队列中展示了可通用性和高预测性能.
- 对于MCC,DeepMerkel的表现优于目前基于人口的预后分期系统.
结论:
- 迪普梅克尔 (DeepMerkel) 是个性化机器学习预测工具在侵袭性皮肤癌症中的典范.
- 开发的工具可以显著帮助MCC的临床管理.
- 可解释性分析为MCC死亡风险因素提供了新的见解.
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Skin Cancer
3.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.1K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328


